Hyperimmune Serum Market
1 Study Coverage
1.1 Hyperimmune Serum Product Introduction
1.2 Market by Type
1.2.1 Global Hyperimmune Serum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Market by Application
1.3.1 Global Hyperimmune Serum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hyperimmune Serum Sales Estimates and Forecasts 2017-2028
2.2 Global Hyperimmune Serum Revenue Estimates and Forecasts 2017-2028
2.3 Global Hyperimmune Serum Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hyperimmune Serum Sales by Region
2.4.1 Global Hyperimmune Serum Sales by Region (2017-2022)
2.4.2 Global Sales Hyperimmune Serum by Region (2023-2028)
2.5 Global Hyperimmune Serum Revenue by Region
2.5.1 Global Hyperimmune Serum Revenue by Region (2017-2022)
2.5.2 Global Hyperimmune Serum Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hyperimmune Serum Sales by Manufacturers
3.1.1 Global Top Hyperimmune Serum Manufacturers by Sales (2017-2022)
3.1.2 Global Hyperimmune Serum Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hyperimmune Serum in 2021
3.2 Global Hyperimmune Serum Revenue by Manufacturers
3.2.1 Global Hyperimmune Serum Revenue by Manufacturers (2017-2022)
3.2.2 Global Hyperimmune Serum Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hyperimmune Serum Revenue in 2021
3.3 Global Hyperimmune Serum Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hyperimmune Serum Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hyperimmune Serum Sales by Type
4.1.1 Global Hyperimmune Serum Historical Sales by Type (2017-2022)
4.1.2 Global Hyperimmune Serum Forecasted Sales by Type (2023-2028)
4.1.3 Global Hyperimmune Serum Sales Market Share by Type (2017-2028)
4.2 Global Hyperimmune Serum Revenue by Type
4.2.1 Global Hyperimmune Serum Historical Revenue by Type (2017-2022)
4.2.2 Global Hyperimmune Serum Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hyperimmune Serum Revenue Market Share by Type (2017-2028)
4.3 Global Hyperimmune Serum Price by Type
4.3.1 Global Hyperimmune Serum Price by Type (2017-2022)
4.3.2 Global Hyperimmune Serum Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hyperimmune Serum Sales by Application
5.1.1 Global Hyperimmune Serum Historical Sales by Application (2017-2022)
5.1.2 Global Hyperimmune Serum Forecasted Sales by Application (2023-2028)
5.1.3 Global Hyperimmune Serum Sales Market Share by Application (2017-2028)
5.2 Global Hyperimmune Serum Revenue by Application
5.2.1 Global Hyperimmune Serum Historical Revenue by Application (2017-2022)
5.2.2 Global Hyperimmune Serum Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hyperimmune Serum Revenue Market Share by Application (2017-2028)
5.3 Global Hyperimmune Serum Price by Application
5.3.1 Global Hyperimmune Serum Price by Application (2017-2022)
5.3.2 Global Hyperimmune Serum Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hyperimmune Serum Market Size by Type
6.1.1 North America Hyperimmune Serum Sales by Type (2017-2028)
6.1.2 North America Hyperimmune Serum Revenue by Type (2017-2028)
6.2 North America Hyperimmune Serum Market Size by Application
6.2.1 North America Hyperimmune Serum Sales by Application (2017-2028)
6.2.2 North America Hyperimmune Serum Revenue by Application (2017-2028)
6.3 North America Hyperimmune Serum Market Size by Country
6.3.1 North America Hyperimmune Serum Sales by Country (2017-2028)
6.3.2 North America Hyperimmune Serum Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hyperimmune Serum Market Size by Type
7.1.1 Europe Hyperimmune Serum Sales by Type (2017-2028)
7.1.2 Europe Hyperimmune Serum Revenue by Type (2017-2028)
7.2 Europe Hyperimmune Serum Market Size by Application
7.2.1 Europe Hyperimmune Serum Sales by Application (2017-2028)
7.2.2 Europe Hyperimmune Serum Revenue by Application (2017-2028)
7.3 Europe Hyperimmune Serum Market Size by Country
7.3.1 Europe Hyperimmune Serum Sales by Country (2017-2028)
7.3.2 Europe Hyperimmune Serum Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hyperimmune Serum Market Size by Type
8.1.1 Asia Pacific Hyperimmune Serum Sales by Type (2017-2028)
8.1.2 Asia Pacific Hyperimmune Serum Revenue by Type (2017-2028)
8.2 Asia Pacific Hyperimmune Serum Market Size by Application
8.2.1 Asia Pacific Hyperimmune Serum Sales by Application (2017-2028)
8.2.2 Asia Pacific Hyperimmune Serum Revenue by Application (2017-2028)
8.3 Asia Pacific Hyperimmune Serum Market Size by Region
8.3.1 Asia Pacific Hyperimmune Serum Sales by Region (2017-2028)
8.3.2 Asia Pacific Hyperimmune Serum Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hyperimmune Serum Market Size by Type
9.1.1 Latin America Hyperimmune Serum Sales by Type (2017-2028)
9.1.2 Latin America Hyperimmune Serum Revenue by Type (2017-2028)
9.2 Latin America Hyperimmune Serum Market Size by Application
9.2.1 Latin America Hyperimmune Serum Sales by Application (2017-2028)
9.2.2 Latin America Hyperimmune Serum Revenue by Application (2017-2028)
9.3 Latin America Hyperimmune Serum Market Size by Country
9.3.1 Latin America Hyperimmune Serum Sales by Country (2017-2028)
9.3.2 Latin America Hyperimmune Serum Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hyperimmune Serum Market Size by Type
10.1.1 Middle East and Africa Hyperimmune Serum Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hyperimmune Serum Revenue by Type (2017-2028)
10.2 Middle East and Africa Hyperimmune Serum Market Size by Application
10.2.1 Middle East and Africa Hyperimmune Serum Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hyperimmune Serum Revenue by Application (2017-2028)
10.3 Middle East and Africa Hyperimmune Serum Market Size by Country
10.3.1 Middle East and Africa Hyperimmune Serum Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hyperimmune Serum Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Behring Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Grifols Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Biotest
11.3.1 Biotest Corporation Information
11.3.2 Biotest Overview
11.3.3 Biotest Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biotest Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest Recent Developments
11.4 Kedrion
11.4.1 Kedrion Corporation Information
11.4.2 Kedrion Overview
11.4.3 Kedrion Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kedrion Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion Recent Developments
11.5 CBPO
11.5.1 CBPO Corporation Information
11.5.2 CBPO Overview
11.5.3 CBPO Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CBPO Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CBPO Recent Developments
11.6 Emergent (Cangene)
11.6.1 Emergent (Cangene) Corporation Information
11.6.2 Emergent (Cangene) Overview
11.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent (Cangene) Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent (Cangene) Recent Developments
11.7 Kamada
11.7.1 Kamada Corporation Information
11.7.2 Kamada Overview
11.7.3 Kamada Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kamada Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kamada Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Overview
11.8.3 CNBG Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CNBG Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Corporation Information
11.9.2 Hualan Bio Overview
11.9.3 Hualan Bio Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Bio Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Bio Recent Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Corporation Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shanghai RAAS Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai RAAS Recent Developments
11.11 Sichuan Yuanda Shuyang
11.11.1 Sichuan Yuanda Shuyang Corporation Information
11.11.2 Sichuan Yuanda Shuyang Overview
11.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sichuan Yuanda Shuyang Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sichuan Yuanda Shuyang Recent Developments
11.12 ADMA Biologics
11.12.1 ADMA Biologics Corporation Information
11.12.2 ADMA Biologics Overview
11.12.3 ADMA Biologics Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ADMA Biologics Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ADMA Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hyperimmune Serum Industry Chain Analysis
12.2 Hyperimmune Serum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hyperimmune Serum Production Mode & Process
12.4 Hyperimmune Serum Sales and Marketing
12.4.1 Hyperimmune Serum Sales Channels
12.4.2 Hyperimmune Serum Distributors
12.5 Hyperimmune Serum Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hyperimmune Serum Industry Trends
13.2 Hyperimmune Serum Market Drivers
13.3 Hyperimmune Serum Market Challenges
13.4 Hyperimmune Serum Market Restraints
14 Key Findings in The Global Hyperimmune Serum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hyperimmune Serum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
Table 3. Major Manufacturers of Rabies Immunoglobulins
Table 4. Major Manufacturers of Tetanus Immunoglobulins
Table 5. Major Manufacturers of Rho(D) Immunoglobulins
Table 6. Major Manufacturers of Other
Table 7. Global Hyperimmune Serum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Hyperimmune Serum Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Hyperimmune Serum Sales by Region (2017-2022) & (Kiloton)
Table 10. Global Hyperimmune Serum Sales Market Share by Region (2017-2022)
Table 11. Global Hyperimmune Serum Sales by Region (2023-2028) & (Kiloton)
Table 12. Global Hyperimmune Serum Sales Market Share by Region (2023-2028)
Table 13. Global Hyperimmune Serum Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Hyperimmune Serum Revenue Market Share by Region (2017-2022)
Table 15. Global Hyperimmune Serum Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Hyperimmune Serum Revenue Market Share by Region (2023-2028)
Table 17. Global Hyperimmune Serum Sales by Manufacturers (2017-2022) & (Kiloton)
Table 18. Global Hyperimmune Serum Sales Share by Manufacturers (2017-2022)
Table 19. Global Hyperimmune Serum Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Hyperimmune Serum Revenue Share by Manufacturers (2017-2022)
Table 21. Hyperimmune Serum Price by Manufacturers (2017-2022) &(US$/Ton)
Table 22. Global Hyperimmune Serum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Hyperimmune Serum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Serum as of 2021)
Table 24. Hyperimmune Serum Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Hyperimmune Serum Product Offered
Table 26. Date of Manufacturers Enter into Hyperimmune Serum Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 29. Global Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 30. Global Hyperimmune Serum Sales Share by Type (2017-2022)
Table 31. Global Hyperimmune Serum Sales Share by Type (2023-2028)
Table 32. Global Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Hyperimmune Serum Revenue Share by Type (2017-2022)
Table 35. Global Hyperimmune Serum Revenue Share by Type (2023-2028)
Table 36. Hyperimmune Serum Price by Type (2017-2022) & (US$/Ton)
Table 37. Global Hyperimmune Serum Price Forecast by Type (2023-2028) & (US$/Ton)
Table 38. Global Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 39. Global Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 40. Global Hyperimmune Serum Sales Share by Application (2017-2022)
Table 41. Global Hyperimmune Serum Sales Share by Application (2023-2028)
Table 42. Global Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Hyperimmune Serum Revenue Share by Application (2017-2022)
Table 45. Global Hyperimmune Serum Revenue Share by Application (2023-2028)
Table 46. Hyperimmune Serum Price by Application (2017-2022) & (US$/Ton)
Table 47. Global Hyperimmune Serum Price Forecast by Application (2023-2028) & (US$/Ton)
Table 48. North America Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 49. North America Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 50. North America Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 53. North America Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 54. North America Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Hyperimmune Serum Sales by Country (2017-2022) & (Kiloton)
Table 57. North America Hyperimmune Serum Sales by Country (2023-2028) & (Kiloton)
Table 58. North America Hyperimmune Serum Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Hyperimmune Serum Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 61. Europe Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 62. Europe Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 65. Europe Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 66. Europe Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Hyperimmune Serum Sales by Country (2017-2022) & (Kiloton)
Table 69. Europe Hyperimmune Serum Sales by Country (2023-2028) & (Kiloton)
Table 70. Europe Hyperimmune Serum Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Hyperimmune Serum Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 73. Asia Pacific Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 74. Asia Pacific Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 77. Asia Pacific Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 78. Asia Pacific Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Hyperimmune Serum Sales by Region (2017-2022) & (Kiloton)
Table 81. Asia Pacific Hyperimmune Serum Sales by Region (2023-2028) & (Kiloton)
Table 82. Asia Pacific Hyperimmune Serum Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Hyperimmune Serum Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 85. Latin America Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 86. Latin America Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 89. Latin America Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 90. Latin America Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Hyperimmune Serum Sales by Country (2017-2022) & (Kiloton)
Table 93. Latin America Hyperimmune Serum Sales by Country (2023-2028) & (Kiloton)
Table 94. Latin America Hyperimmune Serum Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Hyperimmune Serum Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Hyperimmune Serum Sales by Type (2017-2022) & (Kiloton)
Table 97. Middle East and Africa Hyperimmune Serum Sales by Type (2023-2028) & (Kiloton)
Table 98. Middle East and Africa Hyperimmune Serum Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Hyperimmune Serum Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Hyperimmune Serum Sales by Application (2017-2022) & (Kiloton)
Table 101. Middle East and Africa Hyperimmune Serum Sales by Application (2023-2028) & (Kiloton)
Table 102. Middle East and Africa Hyperimmune Serum Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Hyperimmune Serum Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Hyperimmune Serum Sales by Country (2017-2022) & (Kiloton)
Table 105. Middle East and Africa Hyperimmune Serum Sales by Country (2023-2028) & (Kiloton)
Table 106. Middle East and Africa Hyperimmune Serum Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Hyperimmune Serum Revenue by Country (2023-2028) & (US$ Million)
Table 108. CSL Behring Corporation Information
Table 109. CSL Behring Description and Major Businesses
Table 110. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 111. CSL Behring Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. CSL Behring Recent Developments
Table 113. Grifols Corporation Information
Table 114. Grifols Description and Major Businesses
Table 115. Grifols Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 116. Grifols Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Grifols Recent Developments
Table 118. Biotest Corporation Information
Table 119. Biotest Description and Major Businesses
Table 120. Biotest Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 121. Biotest Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Biotest Recent Developments
Table 123. Kedrion Corporation Information
Table 124. Kedrion Description and Major Businesses
Table 125. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 126. Kedrion Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Kedrion Recent Developments
Table 128. CBPO Corporation Information
Table 129. CBPO Description and Major Businesses
Table 130. CBPO Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 131. CBPO Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. CBPO Recent Developments
Table 133. Emergent (Cangene) Corporation Information
Table 134. Emergent (Cangene) Description and Major Businesses
Table 135. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 136. Emergent (Cangene) Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Emergent (Cangene) Recent Developments
Table 138. Kamada Corporation Information
Table 139. Kamada Description and Major Businesses
Table 140. Kamada Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 141. Kamada Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Kamada Recent Developments
Table 143. CNBG Corporation Information
Table 144. CNBG Description and Major Businesses
Table 145. CNBG Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 146. CNBG Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. CNBG Recent Developments
Table 148. Hualan Bio Corporation Information
Table 149. Hualan Bio Description and Major Businesses
Table 150. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 151. Hualan Bio Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Hualan Bio Recent Developments
Table 153. Shanghai RAAS Corporation Information
Table 154. Shanghai RAAS Description and Major Businesses
Table 155. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 156. Shanghai RAAS Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Shanghai RAAS Recent Developments
Table 158. Sichuan Yuanda Shuyang Corporation Information
Table 159. Sichuan Yuanda Shuyang Description and Major Businesses
Table 160. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 161. Sichuan Yuanda Shuyang Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Sichuan Yuanda Shuyang Recent Developments
Table 163. ADMA Biologics Corporation Information
Table 164. ADMA Biologics Description and Major Businesses
Table 165. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 166. ADMA Biologics Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. ADMA Biologics Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Hyperimmune Serum Distributors List
Table 171. Hyperimmune Serum Customers List
Table 172. Hyperimmune Serum Market Trends
Table 173. Hyperimmune Serum Market Drivers
Table 174. Hyperimmune Serum Market Challenges
Table 175. Hyperimmune Serum Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperimmune Serum Product Picture
Figure 3. Global Hyperimmune Serum Market Share by Type in 2021 & 2028
Figure 3. Hepatitis B Immunoglobulins Product Picture
Figure 4. Rabies Immunoglobulins Product Picture
Figure 5. Tetanus Immunoglobulins Product Picture
Figure 6. Rho(D) Immunoglobulins Product Picture
Figure 7. Other Product Picture
Figure 8. Global Hyperimmune Serum Market Share by Application in 2021 & 2028
Figure 9. Government Institutions
Figure 10. Private Sector
Figure 11. Other
Figure 12. Hyperimmune Serum Report Years Considered
Figure 13. Global Hyperimmune Serum Sales 2017-2028 (Kiloton)
Figure 14. Global Hyperimmune Serum Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Hyperimmune Serum Revenue 2017-2028 (US$ Million)
Figure 16. Global Hyperimmune Serum Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Hyperimmune Serum Sales Market Share by Region (2017-2022)
Figure 18. Global Hyperimmune Serum Sales Market Share by Region (2023-2028)
Figure 19. North America Hyperimmune Serum Sales YoY (2017-2028) & (Kiloton)
Figure 20. North America Hyperimmune Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Hyperimmune Serum Sales YoY (2017-2028) & (Kiloton)
Figure 22. Europe Hyperimmune Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Hyperimmune Serum Sales YoY (2017-2028) & (Kiloton)
Figure 24. Asia-Pacific Hyperimmune Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Hyperimmune Serum Sales YoY (2017-2028) & (Kiloton)
Figure 26. Latin America Hyperimmune Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Hyperimmune Serum Sales YoY (2017-2028) & (Kiloton)
Figure 28. Middle East & Africa Hyperimmune Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Hyperimmune Serum Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Hyperimmune Serum in the World: Market Share by Hyperimmune Serum Revenue in 2021
Figure 31. Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 33. Global Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 34. Global Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 35. Global Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 36. North America Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 37. North America Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 38. North America Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 39. North America Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 40. North America Hyperimmune Serum Sales Share by Country (2017-2028)
Figure 41. North America Hyperimmune Serum Revenue Share by Country (2017-2028)
Figure 42. U.S. Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 45. Europe Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 46. Europe Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 47. Europe Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 48. Europe Hyperimmune Serum Sales Share by Country (2017-2028)
Figure 49. Europe Hyperimmune Serum Revenue Share by Country (2017-2028)
Figure 50. Germany Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 51. France Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Hyperimmune Serum Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Hyperimmune Serum Revenue Share by Region (2017-2028)
Figure 61. China Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 64. India Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 72. Latin America Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 74. Latin America Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Hyperimmune Serum Sales Share by Country (2017-2028)
Figure 76. Latin America Hyperimmune Serum Revenue Share by Country (2017-2028)
Figure 77. Mexico Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Hyperimmune Serum Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Hyperimmune Serum Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Hyperimmune Serum Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Hyperimmune Serum Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Hyperimmune Serum Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Hyperimmune Serum Revenue Share by Country (2017-2028)
Figure 86. Turkey Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Hyperimmune Serum Revenue (2017-2028) & (US$ Million)
Figure 89. Hyperimmune Serum Value Chain
Figure 90. Hyperimmune Serum Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Industry Market Size
